Personalized ovarian cancer vaccines spark immunity in phase 1 trial
Rapidly dividing cancer cells can develop DNA mutations that produce abnormal proteins called antigens, which are unique to each patient's cancer. Scientists are now testing personalized cancer vaccines that target these neoantigens and prevent cancer from returning after treatment.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.